CymitQuimica logo

5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2

CAS:

Ref. TR-B699364

5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2
TRC

Product Information

Name:5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2
Controlled Product
Synonyms:
  • 5-Bromo-2,6-dioxohexahydropyrimidine-4-carboxylic Acid-15N2
Brand:TRC
Description:

Applications 5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2 is an intermediate used in the synthesis of Orotic Acid-15N2 Monohydrate (O691504), which is a labeled analogue of Orotic Acid Monohydrate (O691500) that is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. Also, it is the labeled form of 5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid (B699363), an intermediate in synthesizing Orotic Acid Monohydrate (O691500), which is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.

Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:238.995
Formula:C5H5Br15N2O4
Color/Form:Neat
InChI:InChI=1S/C5H5BrN2O4/c6-1-2(4(10)11)7-5(12)8-3(1)9/h1-2H,(H,10,11)(H2,7,8,9,12)/i7+1,8+1
InChI key:InChIKey=TWHXMCSPQHQVFV-BFGUONQLSA-N
SMILES:O=C1[15NH]C(=O)C(Br)C(C(=O)O)[15NH]1

Technical inquiry about: 5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.